Ahan Analytics, LLC

05/24/2026

The Bears Quickly Lose the Market Narrative - The Market Breadth


Early in the week, the market looked ready to confirm a deeper bearish phase as market breadth broke down and selling accelerated. I felt validated in my bearish call for the first two days of the week. However, the bears quickly lost the narrative from there. Buyers broadly stepped in and reversed the tone of the market.

🤑 For more stock market narratives see links in the bio or https://drduru.com/onetwentytwo/blog

========================================
Disclaimer

The contents of this video do not constitute advice and should not be regarded as a recommendation to buy, sell or otherwise deal with any particular investment. The opinions expressed here are Dr. Duru’s alone and do not represent any former or current employer, customer, or partner unless otherwise stated. Any actions taken as a result of information presented here are done at the reader’s risk. Dr. Duru assumes no liability for the outcome of these actions. At any time and without notice, Dr. Duru may buy, sell, or otherwise dispose of trades and investments mentioned in this or any other video or related blogs. Past performance is no guarantee of future results.

05/23/2026

I have taken increasing interest in eGain because the company has survived for decades, and it takes me back to my roots in knowledge management. The generative AI era is made to support a renaissance for this company with deep domain expertise. Here is my latest analysis....

"Upgrading eGain As Market Ignores Compelling Growth Catalysts"

* eGain Corporation is upgraded to a strong buy as business ex*****on outpaces recent stock volatility and valuation resets to attractive levels.
* Q3 2026 results highlight accelerating AI Knowledge Hub growth, robust SaaS margins, and a strengthening balance sheet with $80.5M in cash.
* Guidance reveals surging profitability, improved net income, and potential for renewed share buybacks as cash generation exceeds expectations.
* EGAN's innovation pipeline and deepening pe*******on in regulated sectors position it to capitalize on generative AI adoption and enterprise knowledge transformation.

$EGAN

eGain (EGAN) upgraded to Strong Buy: Q3 FY2026 shows accelerating AI Knowledge Hub growth, strong SaaS margins, and cash. See more here.

05/19/2026

$FIG Is Making A Strong Bid for A Turnaround


Design software company Figma is finally showing the elements of a turnaround. The stock still has a LONG way to go, but if it can hold above its 50-day moving average (currently the downtrend line), it will confirm a bottom in the stock....on the way to a bearish to bullish reversal.

🤑 For more narratives on the financial markets see https://www.drduru.com/onetwentytwo/blog

=====================

Disclaimer

The contents of this video do not constitute advice and should not be regarded as a recommendation to buy, sell or otherwise deal with any particular investment. The opinions expressed here are Dr. Duru’s alone and do not represent any former or current employer, customer, or partner unless otherwise stated. Any actions taken as a result of information presented here are done at the reader’s risk. Dr. Duru assumes no liability for the outcome of these actions. At any time and without notice, Dr. Duru may buy, sell, or otherwise dispose of trades and investments mentioned in this or any other video or related blogs. Past performance is no guarantee of future results.

05/18/2026

A Market Top Looms Larger - The Market Breadth


This is the week I finally had to turn bearish on the stock market. The warning signs have piled up too high for me to continue ignoring them. The momentum in the S&P 500 and NASDAQ has been incredibly strong, and that momentum kept me from making this call earlier. However, the evidence of a market top looming has pushed me off the ledge of my neutral short-term trading call.

🤑 For more details see links in the bio or visit https://drduru.com/onetwentytwo/2026/05/17/a-market-top-looms-large-the-market-breadth/

=====================

Disclaimer

The contents of this video do not constitute advice and should not be regarded as a recommendation to buy, sell or otherwise deal with any particular investment. The opinions expressed here are Dr. Duru’s alone and do not represent any former or current employer, customer, or partner unless otherwise stated. Any actions taken as a result of information presented here are done at the reader’s risk. Dr. Duru assumes no liability for the outcome of these actions. At any time and without notice, Dr. Duru may buy, sell, or otherwise dispose of trades and investments mentioned in this or any other video or related blogs. Past performance is no guarantee of future results.

05/18/2026

A Market Top Looms Large - The Market Breadth
https://drduru.com/onetwentytwo/2026/05/17/a-market-top-looms-large-the-market-breadth/
* The “market top looms” thesis strengthened as deteriorating market breadth, rising bond yields, and weakening consumer-facing stocks diverged sharply from new all-time highs in the S&P 500 and NASDAQ.
* A major IPO fade, bond markets tumbling (lower prices, higher yields), further deterioration in market breadth, increasing weakness in consumer-facing stocks, and bulls “trapped” chasing all-time highs, all point to a major warning of an imminent market top.
* Rising volatility risk remained a concern as the VIX held support despite continued index strength, creating conditions consistent with a potential market correction.

$SPY $COMPQ $IWM $TLT $SLV $BHP $TJX $WING $ANF $BIRK $DLTR $DG $CASY $ITB $KBH $IGV $IBM $OWL $FIG $DRAM $ISRG $ZM $FSLR $CHRW

Market top looms as breadth deteriorates, bond yields surge, and consumer-facing stocks weaken beneath record index highs.

05/16/2026

Epilogue On Esperion Therapeutics (Rating Downgrade) $ESPR
https://seekingalpha.com/article/4905593?gt=b466cee5e576a611
* Esperion Therapeutics is being acquired by ARCHIMED, with shareholders receiving Contingent Value Rights (CVRs) tied to future milestone payments.
* ESPR's CVRs could yield a maximum of 31.6 cents per share in two years, equating to an annualized yield of roughly 5% in the best-case scenario.
* Milestone payouts hinge on net product sales exceeding $160M and $350M in different timeframes, with Japan expected to drive significant sales growth post-approval.
* I am downgrading ESPR to hold, preferring to take profits now due to ex*****on risk and dilution, despite strong sales incentives under the acquisition structure.

Esperion Therapeutics is being acquired by ARCHIMED, with shareholders receiving CVRs tied to future milestone payments. See why ESPR stock is downgraded to hold.

05/14/2026

My latest interview with the CEO of African e-commerce company Jumia Technologies.

https://seekingalpha.com/article/4904904?gt=15a4310f148e7772

* Jumia Technologies is rated a strong buy, with momentum toward profitability continuing despite a 38% YTD stock decline.
* JMIA hit the top end of Q1 GMV growth guidance, maintained the breakeven target for Q4, and expects full-year 2027 profitability.
* Upcountry expansion, the Starlink partnership, and AI-driven cost efficiencies are adding to growth and operational improvements across key African markets.
* Competitive logistics advantages and resilient ex*****on position JMIA as a leading African e-commerce player, with a current valuation offering an attractive entry point.

$JMIA

Jumia Technologies is rated a Strong Buy, with momentum toward profitability continuing despite a 38% YTD stock decline. Read more on JMIA stock here.

05/14/2026

PAIROS on ServiceNow: Strong Prospects Awaiting More Evidence

https://drduru.com/onetwentytwo/2026/05/14/pairos-on-servicenow-strong-prospects-awaiting-more-evidence/

$NOW

ServiceNow’s AI governance strategy earned high PAIROS ratings despite investor panic after weak-looking Q1 earnings and margin concerns.

05/14/2026

$MU Just Invalidated Market’s Bearish Breadth Signal


Market breadth has been bearish for almost a month. Yet, the S&P 500 and the NASDAQ continue higher with new all-time highs. Micron Technology ($MU) is a great example of the bullish side of this sharp and unusual divergence. $MU printed a blow-off top only to invalidate the bearish signal with another all-time high the very next day. How long can this last? Momentum and trend is your friend.

🤑 For more narratives on the financial markets see https://www.drduru.com/onetwentytwo/blog

=============================

Disclaimer

The contents of this video do not constitute advice and should not be regarded as a recommendation to buy, sell or otherwise deal with any particular investment. The opinions expressed here are Dr. Duru’s alone and do not represent any former or current employer, customer, or partner unless otherwise stated. Any actions taken as a result of information presented here are done at the reader’s risk. Dr. Duru assumes no liability for the outcome of these actions. At any time and without notice, Dr. Duru may buy, sell, or otherwise dispose of trades and investments mentioned in this or any other video or related blogs. Past performance is no guarantee of future results.

05/12/2026

Retail Stocks Need $TJX To Hold 200DMA Support


$TJX has not touched its uptrending 200-day moving average (DMA) in 10 months. Will the current test of this support hold up? If not, it could signal the beginning of an extended bearish run for retail stocks. Market breadth has been weighed down by consumer-facing stocks. Retail is the most visible sign of trouble as oil prices remain higher for longer.

🤑 For more narratives on the financial markets see links in the bio or https://www.drduru.com/onetwentytwo/blog

=====================

Disclaimer

The contents of this video do not constitute advice and should not be regarded as a recommendation to buy, sell or otherwise deal with any particular investment. The opinions expressed here are Dr. Duru’s alone and do not represent any former or current employer, customer, or partner unless otherwise stated. Any actions taken as a result of information presented here are done at the reader’s risk. Dr. Duru assumes no liability for the outcome of these actions. At any time and without notice, Dr. Duru may buy, sell, or otherwise dispose of trades and investments mentioned in this or any other video or related blogs. Past performance is no guarantee of future results.

05/11/2026

AI Stocks Power Away from Bearish Market Breadth

https://drduru.com/onetwentytwo/2026/05/10/ai-stocks-power-away-from-bearish-market-breadth/

* AI infrastructure stocks power away from bearish market breadth as the S&P 500 and NASDAQ hit fresh all-time highs.
* Market breadth remains bearish, with AT50 fading below overbought territory and AT200 still moving sideways.
* Semiconductor, AI infrastructure, and select AI-related software stocks drive momentum while consumer-facing and financial stocks lag.
* The trading call remains neutral because index strength is powerful but breadth, volatility, and sector divergence still warn of imminent risk.

​ $SPY $COMPQ $IWM $SMH $SNDK $AMD $AKAM $FSLY $DDOG $IGV $FROG $PANW $NET $CDW $YELP $TOST $SHAK $SHOP $DASH $XLF $XYZ $CCRN $EXPD

AI infrastructure stocks continued to power away from weak market breadth as semiconductor and software names surged to new highs while consumer and financial stocks lagged behind.